The High Court has ordered 20 pharmaceutical companies to stop production of all medicines and 14 others to stop production of antibiotics over the allegation of failure in producing standard quality medicines. The court also ordered the government to form a five-member committee to submit its report quarterly and monitor whether the directives were implemented. The lawyer of the writ petitioner Manjil Morshed said, government has already canceled the licenses of 11 pharmaceuticals among the 34. The 20 companies which were banned from producing all medicines are: Exim Pharmaceuticals, Avert Pharma Ltd, Bikalpa Pharmaceuticals Ltd, Dolphin Pharmaceuticals Ltd, Drugland Ltd, Globe Laboratories Pvt Ltd, Jolpa Laboratories Ltd, Kafma Pharmaceuticals Ltd, Medico Pharmaceuticals Ltd, National Drug Pharma Ltd, North Bengal Pharmaceuticals Ltd, Rimo Chemicals Ltd, Rid Pharmaceuticals Ltd, Skylab Pharmaceuticals Ltd, Spark Pharmaceuticals Ltd, Star Pharmaceuticals Ltd, Shunipun Pharmaceuticals Ltd, Today Pharmaceuticals Ltd, Tropical Pharmaceuticals Ltd and Universal Pharmaceuticals LtdAlso read: Bangladesh: Girl suffering from 'tree man' syndrome successful undergoes surgeryFourteen companies banned from producing antibiotics are: Ad-din Pharmaceutical Ltd, Alkad Laboratories Ltd, Belsen Pharmaceuticals Ltd, Bengal Drugs and Chemicals (Pharma) Ltd, Bristol Pharma Ltd, Crystal Pharmaceuticals Ltd, Indo-Bangla Pharmaceuticals Ltd, Millat Pharmaceuticals Ltd, MST Pharma and Healthcare Ltd, Orbit Pharmaceuticals Ltd, Pharmic Laboratories ltd, Phoenix Chemical Laboratory Ltd, Rasa Pharmaceuticals Ltd and Save Pharmaceuticals Ltd. Meanwhile, lawyer of the pharmaceutical companies said they will appeal against the judgement.

Source: India Today February 13, 2017 17:26 UTC